ERBB2 and breast cancer: Furthermore, Manzano and colleagues reported that PLPP4 was upregulated in only the estrogen receptor (ER)-ERBB2+ subgroup, but not in other subtypes of breast cancer, suggesting a specific role of PLPP4 in ER-ERBB2+ subtypes [21].